THE FORGOTTEN GROUP AT RISK FOR BREAST-CANCER

被引：2

作者：

JORDAN, VC

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1990年 / 8卷 / 08期

关键词：

D O I：

10.1200/JCO.1990.8.8.1445

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1445 / 1446

页数：2

共 10 条

[1]

BAUM M, 1985, LANCET, V1, P836

[2]

CUZICK J, 1985, LANCET, V2, P282

[3] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484

[4]

FORNANDER T, 1989, LANCET, V1, P117

[5] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].

FURR, BJA ;

JORDAN, VC .

PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205

[6] EFFECT OF TAMOXIFEN (ICI 46,474) ON INITIATION AND GROWTH OF DMBA - INDUCED RAT MAMMARY CARCINOMATA [J].

JORDAN, VC .

EUROPEAN JOURNAL OF CANCER, 1976, 12 (06) :419-424

[7]

JORDAN VC, IN PRESS EUR J CANCE

[8]

JORDAN VC, 1990, BREAST CANCER RES TR, V5, P125

[9]

1987, LANCET, V2, P171

[10]

1988, NEW ENGL J MED, V319, P1681

← 1 →